RxSight (RXST) FCF Margin Growth (1y) (2021 - 2026)
RxSight (RXST) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | -473.00 |
| 10 | RxSight | 249.15 Mn | -155.09 Mn | - | -1,649.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,649.00 |
| Mar 31, 2026 | -1,387.00 |
| Dec 31, 2025 | 840.00 |
| Sep 30, 2025 | 389.00 |
| Jun 30, 2025 | -277.00 |
| Mar 31, 2025 | 1,436.00 |
| Dec 31, 2024 | 2,191.00 |
| Sep 30, 2024 | 4,735.00 |
| Jun 30, 2024 | 2,107.00 |
| Mar 31, 2024 | 6,485.00 |
| Dec 31, 2023 | 4,074.00 |
| Sep 30, 2023 | 7,636.00 |
| Jun 30, 2023 | 10,302.00 |
| Mar 31, 2023 | 6,866.00 |
| Dec 31, 2022 | 2,653.00 |
| Sep 30, 2022 | 9,229.00 |
| Jun 30, 2022 | 12,143.00 |
| Mar 31, 2022 | 13,684.00 |
| Dec 31, 2021 | -16,840.00 |
| Sep 30, 2021 | -3,620.00 |